King Pharmaceuticals
Subscribe to King Pharmaceuticals

The Lead

King, Acura Say FDA Does Not Need New Acurox Trial

September 4, 2009 6:29 am | News | Comments

NEW YORK (AP) — King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. said Friday they don't expect to have to run new clinical trials of an abuse-resistant pain drug in order to gain Food and Drug Administration approval.

Durect Signs Remoxy Supply Deal With King

August 27, 2009 8:02 am | News | Comments

CUPERTINO, Calif. (AP) — Drug developer Durect Corp. said Thursday it signed a long-term agreement...

King Pharma, Pain Therapeutics to Resubmit Remoxy

July 7, 2009 6:10 am | News | Comments

NEW YORK (AP) — King Pharmaceuticals Inc. and partner Pain Therapeutics Inc. expect to resubmit an...

King Pharmaceuticals Reports 1Q loss

May 11, 2009 4:44 am | News | Comments

BRISTOL, Tenn. (AP) — Drug developer King Pharmaceuticals Inc. reported a first-quarter loss Monday...

View Sample

FREE Email Newsletter

King Pharma CEO's Pay Falls by Nearly Half in 2008

April 24, 2009 4:49 am | News | Comments

MARLEY SEAMAN AP Health Writer NEW YORK (AP) — King Pharmaceuticals Inc. in 2008 paid its chief executive a little more than half his compensation from the previous year, largely because of a decline in stock and options awards, according to an Associated Press analysis of a regulatory filing.

King Pharma Loses $548M in 4Q, Cites Buyout Costs

February 26, 2009 4:30 am | News | Comments

BRISTOL, Tenn. (AP) — King Pharmaceuticals Inc. said Thursday it lost almost $550 million in the fourth quarter, largely due to the costs of acquiring rival Alpharma Inc. The company also lost patent protection on its painkiller Altace a year ago, which caused sales to drop.

FDA Seeks Plans To Reduce Misuse Of Painkillers

February 10, 2009 4:54 am | News | Comments

By MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — Federal health regulators are requiring more than a dozen drugmakers to develop plans to reduce the misuse of their painkillers, which cause hundreds of deaths each year.


Acura Gets $3 Million Under King Licensing Deal

December 24, 2008 6:06 am | News | Comments

NEW YORK (AP) - Acura Pharmaceuticals Inc. will receive a $3 million payment from King Pharmaceuticals under a continuing licensing deal, the companies said Wednesday. Bristol, Tenn.-based King exercised its option to license a fourth immediate-release pain treatment using Palatine, Ill.

King Pharmaceuticals Extends Alpharma Buyout Offer

December 22, 2008 5:36 am | News | Comments

NEW YORK (AP) — King Pharmaceuticals Inc. extended its $37-per-share buyout offer for Alpharma Inc. on Monday and has already acquired about 92 percent of the company's outstanding stock. The offer is now extended to 10.a.m. Dec. 29. It was set to expire Dec. 19.Bridgewater, N.J.

King Pharma's $1.6B offer wins over Alpharma

December 1, 2008 6:53 am | News | Comments

NEW YORK (AP) _ Alpharma Inc. has finally agreed to King Pharmaceuticals Inc.'s $1.6 billion cash takeover offer, ending the drugmakers' months-long battle. Last Monday, Bristol, Tenn.

King Pharmaceuticals Extends Tender Offer to Acquire Alpharma

October 13, 2008 9:26 am | News | Comments

King Pharmaceuticals, Inc. has announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. until 5:00 pm, New York City time, on November 21, 2008, unless the offer is further extended.

Alpharma Board Rejects King Pharmaceuticals' Unsolicited Tender Offer as "Financially Inadequate"

September 30, 2008 9:25 am | News | Comments

The Board of Directors of Alpharma Inc., a global specialty pharmaceutical company, recently filed


Alpharma Urges Shareholders to Take No Action with Respect to King Pharmaceuticals' Announced Intent to Commence a Tender Offer

September 15, 2008 12:54 pm | News | Comments

The Board of Directors of Alpharma Inc., a global specialty pharmaceutical company, has urged shareholders to take no action with respect to the announcement by King Pharmaceuticals, Inc.

Manufacturing Facility

February 21, 2007 7:54 am | News | Comments

King Pharmaceuticals, Inc. recently announced that the FDA has approved the company's new state-of-the-art manufacturing and production facility in Rochester, Michigan for its Bicillin® product line.

Antibiotic Warning Labels Toughened by FDA

December 8, 2004 4:09 am | Product Releases | Comments

WASHINGTON, DC (December 7, 2004) – The Food & Drug Administration (FDA) last week announced labeling changes regarding Bicillin CR (penicillin G benzathine and penicillin G procaine injectable suspension) and Bicillin LA (penicillin G benzathine injectable suspension).

King Pharmaceuticals Announces Brian A. Markison as President and CEO

July 19, 2004 6:02 am | Product Releases | Comments

BRISTOL, TN (July 19, 2004) - King Pharmaceuticals, Inc. reported that they have selected Brian A. Markison as King's president and CEO. He has also been elected to the board of directors.

Top King Pharmaceuticals Executive Resigns

May 24, 2004 7:51 am | Product Releases | Comments

BRISTOL, TN (May 24, 2004) – Jefferson J. Gregory has resigned as chairman and chief executive officer of King Pharmaceuticals, Inc., the company said last week. The company said its board of directors accepted Gregory's resignation, which was effective May 14.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.